Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
97
PharmaCompass offers a list of Benfotiamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benfotiamine manufacturer or Benfotiamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benfotiamine manufacturer or Benfotiamine supplier.
PharmaCompass also assists you with knowing the Benfotiamine API Price utilized in the formulation of products. Benfotiamine API Price is not always fixed or binding as the Benfotiamine Price is obtained through a variety of data sources. The Benfotiamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benfotiamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benfotiamine, including repackagers and relabelers. The FDA regulates Benfotiamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benfotiamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benfotiamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benfotiamine supplier is an individual or a company that provides Benfotiamine active pharmaceutical ingredient (API) or Benfotiamine finished formulations upon request. The Benfotiamine suppliers may include Benfotiamine API manufacturers, exporters, distributors and traders.
click here to find a list of Benfotiamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benfotiamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Benfotiamine active pharmaceutical ingredient (API) in detail. Different forms of Benfotiamine DMFs exist exist since differing nations have different regulations, such as Benfotiamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benfotiamine DMF submitted to regulatory agencies in the US is known as a USDMF. Benfotiamine USDMF includes data on Benfotiamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benfotiamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benfotiamine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Benfotiamine Drug Master File in Japan (Benfotiamine JDMF) empowers Benfotiamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Benfotiamine JDMF during the approval evaluation for pharmaceutical products. At the time of Benfotiamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Benfotiamine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Benfotiamine Drug Master File in Korea (Benfotiamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Benfotiamine. The MFDS reviews the Benfotiamine KDMF as part of the drug registration process and uses the information provided in the Benfotiamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Benfotiamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Benfotiamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Benfotiamine suppliers with KDMF on PharmaCompass.
A Benfotiamine written confirmation (Benfotiamine WC) is an official document issued by a regulatory agency to a Benfotiamine manufacturer, verifying that the manufacturing facility of a Benfotiamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Benfotiamine APIs or Benfotiamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Benfotiamine WC (written confirmation) as part of the regulatory process.
click here to find a list of Benfotiamine suppliers with Written Confirmation (WC) on PharmaCompass.
Benfotiamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benfotiamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benfotiamine GMP manufacturer or Benfotiamine GMP API supplier for your needs.
A Benfotiamine CoA (Certificate of Analysis) is a formal document that attests to Benfotiamine's compliance with Benfotiamine specifications and serves as a tool for batch-level quality control.
Benfotiamine CoA mostly includes findings from lab analyses of a specific batch. For each Benfotiamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benfotiamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Benfotiamine EP), Benfotiamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benfotiamine USP).
